Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.

Literature DB >> 24247139

In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.

Louise M Oleksiuk¹, M Hong Nguyen, Ellen G Press, Cassaundra L Updike, Jessica A O'Hara, Yohei Doi, Cornelius J Clancy, Ryan K Shields.

Abstract

We compared in vitro killing of colistin, doripenem, and sulbactam by time-kill methods against Acinetobacter baumannii isolates collected from patients before and after colistin-doripenem treatment (initial and recurrent isolates, respectively). Colistin-doripenem bactericidal activity against recurrent isolates was attenuated (mean log10 kill, -5.74 versus -2.88; P = 0.01) but was restored by adding sulbactam. Doripenem MICs rather than colistin MICs correlated with the activity of colistin-doripenem. Among colistin-resistant isolates, colistin-doripenem-sulbactam combinations achieved greater killing than colistin-doripenem alone (-5.65 versus -2.43; P = 0.04).

Entities: Chemical Species

Mesh：

Substances：

Year: 2013 PMID： 24247139 PMCID： PMC3910865 DOI： 10.1128/AAC.01779-13

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

12 in total

1. Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.

Authors: Marie Kempf; Lamia Djouhri-Bouktab; Jean-Michel Brunel; Didier Raoult; Jean-Marc Rolain
Journal: Int J Antimicrob Agents Date: 2011-11-17 Impact factor: 5.283

Review 2. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.

Authors: Robert A Bonomo; Dora Szabo
Journal: Clin Infect Dis Date: 2006-09-01 Impact factor: 9.079

3. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.

Authors: Ryan K Shields; Eun J Kwak; Brian A Potoski; Yohei Doi; Jennifer M Adams-Haduch; Fernanda P Silviera; Yoshiya Toyoda; Joseph M Pilewski; Maria Crespo; A William Pasculle; Cornelius J Clancy; M Hong Nguyen
Journal: Diagn Microbiol Infect Dis Date: 2011-02-25 Impact factor: 2.803

4. Sulbactam: biochemical factors involved in its synergy with ampicillin.

Authors: R Labia; A Morand; V Lelievre; D Mattioni; A Kazmierczak
Journal: Rev Infect Dis Date: 1986 Nov-Dec

5. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii.

Authors: Carlos R V Kiffer; Jorge L M Sampaio; Sumiko Sinto; Carmen P Oplustil; Paula C M Koga; Andréa C Arruda; Philip J Turner; Caio Mendes
Journal: Diagn Microbiol Infect Dis Date: 2005-08 Impact factor: 2.803

6. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors: S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal: Antimicrob Agents Chemother Date: 2011-05-09 Impact factor: 5.191

7. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.

Authors: J Y Choi; Y Soo Park; C H Cho; Y Seon Park; S Y Shin; Y G Song; D Yong; K Lee; J M Kim
Journal: Clin Microbiol Infect Date: 2004-12 Impact factor: 8.067

8. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii.

Authors: Felipe Fernández-Cuenca; Luis Martínez-Martínez; Maria Carmen Conejo; Juan A Ayala; Evelio J Perea; Alvaro Pascual
Journal: J Antimicrob Chemother Date: 2003-03 Impact factor: 5.790

9. Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.

Authors: Cornelius J Clancy; Liang Chen; Jae H Hong; Shaoji Cheng; Binghua Hao; Ryan K Shields; Annie N Farrell; Yohei Doi; Yanan Zhao; David S Perlin; Barry N Kreiswirth; M Hong Nguyen
Journal: Antimicrob Agents Chemother Date: 2013-08-12 Impact factor: 5.191

10. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.

Authors: Jennifer M Adams-Haduch; David L Paterson; Hanna E Sidjabat; Anthony W Pasculle; Brian A Potoski; Carlene A Muto; Lee H Harrison; Yohei Doi
Journal: Antimicrob Agents Chemother Date: 2008-08-25 Impact factor: 5.191

16 in total

Review 1. Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors: Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal: Clin Microbiol Rev Date: 2017-01 Impact factor: 26.132

2. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.

Authors: Zubair A Qureshi; Lauren E Hittle; Jessica A O'Hara; Jesabel I Rivera; Alveena Syed; Ryan K Shields; Anthony W Pasculle; Robert K Ernst; Yohei Doi
Journal: Clin Infect Dis Date: 2015-01-28 Impact factor: 9.079

3. Correlation of Checkerboard Synergy Testing with Time-Kill Analysis and Clinical Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Respiratory Infections.

Authors: Derek N Bremmer; Karri A Bauer; Stephanie M Pouch; Keelie Thomas; Debra Smith; Debra A Goff; Preeti Pancholi; Joan-Miquel Balada-Llasat
Journal: Antimicrob Agents Chemother Date: 2016-10-21 Impact factor: 5.191

10. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.

Authors: Gyun Cheol Park; Ji Ae Choi; Sook Jin Jang; Seok Hoon Jeong; Choon-Mee Kim; In Sun Choi; Seong Ho Kang; Geon Park; Dae Soo Moon
Journal: Ann Lab Med Date: 2016-03 Impact factor: 3.464